ST. LOUIS–(BUSINESS WIRE)–Cofactor Genomics, Inc., a commercial-stage company bridging the precision medicine gap by decoding RNA, announced that experienced industry leader Chris Parker has been named CEO and Board Member to lead Cofactor’s plan to bring precision medicine to immunotherapy. Simultaneously, the company announced that Jarret Glasscock, scientist and Cofactor Genomics founder, will transition into the role of President, Chief Technology Officer (CTO), and Board Member. Parker j

OTTAWA–(BUSINESS WIRE)–In 2024, Ontario’s health care crisis reached new lows: the number of patients in hospital hallways hit a record high; ER closures broke a new threshold; the wait-list for long-term care beds peaked at 48,000, 250,000 people languished on the surgical waitlist and 2.5 million people did not have a family doctor. And yet, advocates say, instead of addressing this crisis the government is needlessly focused on an early election campaign. On Thursday, January 9, Ottawa com

LYON, France–(BUSINESS WIRE)—- $MAAT #Cancer–Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today announced topline results from ARES, a pivotal, single-arm, open-label, multicenter European Phase 3 study evaluating the efficacy and safety of MaaT013 in acute Graft-versus-Host Disease patients with

NEW YORK–(BUSINESS WIRE)–The DiPietro Law Firm filed new round of lawsuits on behalf of another 80 former patients of Columbia University and its felon OB/GYN Robert A. Hadden

DUBLIN–(BUSINESS WIRE)–The “Smart Home Healthcare Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Technology, Region, By Country: 2020-2030” report has been added to ResearchAndMarkets.com’s offering. Global Smart Home Healthcare Market valued at USD 5.03 Billion in 2023 is expected to grow at a CAGR of 9.2% during 2025-2030. The Smart Home Healthcare market has witnessed substantial growth in recent years, driven by the increasing adoption o

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics, a leader in clinical genomic testing, today announced its contribution to a study published in Nature that significantly advances our understanding of BRCA2 gene variants. As the uptake of genetic testing continues to grow, the need for scalable interpretation of the vast number of variants detected has become critical. This study was designed to leverage CRISPR/cas-9 gene editing to aid in the functional characterization of nearly 7,000 BRC

LOS ANGELES–(BUSINESS WIRE)– #childrenshealth–After many months of researching and exploring some of the most complex challenges facing children in a post-pandemic world, experts from L.A. Care Health Plan, the nation’s largest publicly operated plan, and Children’s Hospital Los Angeles (CHLA), one of the nation’s leading pediatric hospitals, unveiled their first-ever Los Angeles County State of Children’s Health report. The report, made up of four policy briefs, identified core issues impacting kids and teens

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics Market Report 2024-2034” report has been added to ResearchAndMarkets.com’s offering. Overall world revenue for the In Vitro Diagnostics Market will surpass US$100 billion in 2024 The In Vitro Diagnostics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand i

SAN DIEGO–(BUSINESS WIRE)–Element Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

CARLSBAD, Calif.–(BUSINESS WIRE)–Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients is associated with lower healthcare resource utilization (HCRU) and a significant reduction in associated costs., including a 61% overall reduction in outpatient costs.1 This independently analyzed real-world study conducted by research firm OM1 evaluated medical